Related references
Note: Only part of the references are listed.Treatment Efficacy and Immune Stimulation by AdCD40L Gene Therapy of Spontaneous Canine Malignant Melanoma
Sara Westberg et al.
JOURNAL OF IMMUNOTHERAPY (2013)
Genetically engineered T cells for the treatment of cancer
M. Essand et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Macrophages in Tumor Microenvironments and the Progression of Tumors
Ning-Bo Hao et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Coordinated regulation of myeloid cells by tumours
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Tissue-based class control: the other side of tolerance
Polly Matzinger et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Immune Stimulatory Receptor CD40 Is Required for T-Cell Suppression and T Regulatory Cell Activation Mediated by Myeloid-Derived Suppressor Cells in Cancer
Ping-Ying Pan et al.
CANCER RESEARCH (2010)
AdCD40L Immunogene Therapy for Bladder Carcinoma-The First Phase I/IIa Trial
Per-Uno Malmstrom et al.
CLINICAL CANCER RESEARCH (2010)
Transforming growth factor beta (TGF-β) and inflammation in cancer
Brian Bierie et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF
Luigi Dolcetti et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Enhanced Tumor Eradication by Combining CTLA-4 or PD-1 Blockade With CpG Therapy
Sara M. Mangsbo et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Subsets, expansion and activation of myeloid-derived suppressor cells
Eliana Ribechini et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2010)
Adoptive cell therapy for the treatment of patients with metastatic melanoma
Steven A. Rosenberg et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Suzanne Ostrand-Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2009)
Local AdCD40L Gene Therapy is Effective for Disseminated Murine Experimental Cancer by Breaking T-cell Tolerance and Inducing Tumor Cell Growth Inhibition
Camilla Lindqvist et al.
JOURNAL OF IMMUNOTHERAPY (2009)
The Janus faces of CD40 in cancer
Angelica S. I. Loskog et al.
SEMINARS IN IMMUNOLOGY (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity
Kiavash Movahedi et al.
BLOOD (2008)
Subsets of myeloid-derived suppressor cells in tumor-bearing mice
Je-In Youn et al.
JOURNAL OF IMMUNOLOGY (2008)
Efficient adenovector CD40 ligand immunotherapy of canine malignant melanoma
Henrik von Euler et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics
Naoki Umemura et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
AdCD40L gene therapy counteracts T regulatory cells and cures aggressive tumors in an orthotopic bladder cancer model
ASI Loskog et al.
CLINICAL CANCER RESEARCH (2005)
Interleukin-10 and the immune response against cancer: a counterpoint
S Mocellin et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Adenovirus CD40 ligand gene therapy counteracts immune escape mechanisms in the tumor microenvironment
A Loskog et al.
JOURNAL OF IMMUNOLOGY (2004)
Share Paper
